It is thus interesting to hypothesize that increased eosinophil counts are either a biomarker for a Th2-mediated graft rejection and/or damaged lung graft epithelial cells, which by secreting IL-33 promote IL-5-expressing ILC2s, eventually inducing eosinophilia. The gene discussed is IL5; the disease is Increased total eosinophil count.